Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Low-level laser treatment helped rats regrow hair faster after chemotherapy.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Understanding chaos and control mechanisms in disease can improve diagnosis and prediction in medicine.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Tailor treatments for vitiligo to patient needs for best results.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Low-Level Laser Therapy may help with flap survival and burn scar healing, but not with venous ulcers or hair loss, and more research is needed.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.